MedPath

A clinical trial to study the effect of individualised homoeopathic medicine (similimum) on modifying the anger of patients having mild to moderate essential hypertension and thereby reducing the raised blood pressure against standard antihypertensive treatment

Phase 2
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2019/10/021507
Lead Sponsor
DrLeena Bagadia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of essential hypertension

Exclusion Criteria

Patients having secondary hypertension

Pregnant and lactating women

Uncontrolled endocrine disorders

Severe psychiatric disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath